BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 10676816)

  • 21. Molecular characterization of the Caenorhabditis elegans Rho GDP-dissociation inhibitor.
    Yap SF; Chen W; Lim L
    Eur J Biochem; 1999 Dec; 266(3):1090-100. PubMed ID: 10583406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors.
    Platko JV; Leonard DA; Adra CN; Shaw RJ; Cerione RA; Lim B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2974-8. PubMed ID: 7708758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes.
    Forget MA; Desrosiers RR; Gingras D; Béliveau R
    Biochem J; 2002 Jan; 361(Pt 2):243-54. PubMed ID: 11772396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI).
    Fauré J; Dagher MC
    Biochimie; 2001 May; 83(5):409-14. PubMed ID: 11368848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE.
    Buchwald G; Friebel A; Galán JE; Hardt WD; Wittinghofer A; Scheffzek K
    EMBO J; 2002 Jul; 21(13):3286-95. PubMed ID: 12093730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition and stabilization of geranylgeranylated human Rab5 by the GDP Dissociation Inhibitor (GDI).
    Edler E; Stein M
    Small GTPases; 2019 May; 10(3):227-242. PubMed ID: 29065764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrostatic Forces Mediate the Specificity of RHO GTPase-GDI Interactions.
    Mosaddeghzadeh N; Kazemein Jasemi NS; Majolée J; Zhang SC; Hordijk PL; Dvorsky R; Ahmadian MR
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RhoGDI-binding-defective mutant of Cdc42Hs targets to membranes and activates filopodia formation but does not cycle with the cytosol of mammalian cells.
    Gibson RM; Wilson-Delfosse AL
    Biochem J; 2001 Oct; 359(Pt 2):285-94. PubMed ID: 11583574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human RhoA/RhoGDI complex expressed in yeast: GTP exchange is sufficient for translocation of RhoA to liposomes.
    Read PW; Liu X; Longenecker K; Dipierro CG; Walker LA; Somlyo AV; Somlyo AP; Nakamoto RK
    Protein Sci; 2000 Feb; 9(2):376-86. PubMed ID: 10716190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between Cdc42Hs and RhoGDI is mediated through the Rho insert region.
    Wu WJ; Leonard DA; A-Cerione R; Manor D
    J Biol Chem; 1997 Oct; 272(42):26153-8. PubMed ID: 9334181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Rho GTPases by DOCK exchange factors is mediated by a nucleotide sensor.
    Yang J; Zhang Z; Roe SM; Marshall CJ; Barford D
    Science; 2009 Sep; 325(5946):1398-402. PubMed ID: 19745154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential phosphorylation of RhoGDI mediates the distinct cycling of Cdc42 and Rac1 to regulate second-phase insulin secretion.
    Wang Z; Thurmond DC
    J Biol Chem; 2010 Feb; 285(9):6186-97. PubMed ID: 20028975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of prenylated RhoA interaction with its chaperone, RhoGDI.
    Tnimov Z; Guo Z; Gambin Y; Nguyen UT; Wu YW; Abankwa D; Stigter A; Collins BM; Waldmann H; Goody RS; Alexandrov K
    J Biol Chem; 2012 Aug; 287(32):26549-62. PubMed ID: 22628549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation.
    Groysman M; Russek CS; Katzav S
    FEBS Lett; 2000 Feb; 467(1):75-80. PubMed ID: 10664460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Rho protein binding to membranes by rhoGDI: inhibition of releasing activity by physiological ionic conditions.
    Bilodeau D; Lamy S; Desrosiers RR; Gingras D; Béliveau R
    Biochem Cell Biol; 1999; 77(1):59-69. PubMed ID: 10426287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel role for RhoGDI as an inhibitor of GAP proteins.
    Hancock JF; Hall A
    EMBO J; 1993 May; 12(5):1915-21. PubMed ID: 8491184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RhoGDI-3 regulates RhoG and targets this protein to the Golgi complex through its unique N-terminal domain.
    Brunet N; Morin A; Olofsson B
    Traffic; 2002 May; 3(5):342-57. PubMed ID: 11967128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs.
    Hart MJ; Maru Y; Leonard D; Witte ON; Evans T; Cerione RA
    Science; 1992 Oct; 258(5083):812-5. PubMed ID: 1439791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallization and preliminary crystallographic studies of RhoGDI in complex with the radixin FERM domain.
    Hamada K; Seto A; Shimizu T; Matsui T; Takai Y; Tsukita S; Tsukita S; Hakoshima T
    Acta Crystallogr D Biol Crystallogr; 2001 Jun; 57(Pt 6):889-90. PubMed ID: 11375519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The specific binding of small molecule isoprenoids to rhoGDP dissociation inhibitor (rhoGDI).
    Mondal MS; Wang Z; Seeds AM; Rando RR
    Biochemistry; 2000 Jan; 39(2):406-12. PubMed ID: 10631002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.